Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade
Authors:
- 13 June 2003
- journal article
- clinical trial
- Published by Springer Nature in Pediatric Nephrology
- Vol. 18 (8) , 772-777
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Premature acute myocardial infarction in a child with nephrotic syndromePediatric Nephrology, 2002
- Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonistsKidney International, 2000
- A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosisKidney International, 1999
- Aggressive treatment of severe idiopathic focal segmental glomerulosclerosisPediatric Nephrology, 1999
- Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable diseasePediatric Nephrology, 1996
- Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilImmunological Reviews, 1993
- Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic childrenThe Journal of Pediatrics, 1990
- Effect of Methylprednisolone Pulse Therapy on Cellular Immunity Abnormalities in a Patient with Lipoid NephrosisNephron, 1990
- Acute and Long-term Complications of Corticosteroid Pulse TherapyScandinavian Journal of Rheumatology, 1984
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisoneThe Journal of Pediatrics, 1981